Display options
Cite
Lomeli N, Bota DA. Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic. Transl Cancer Res. 2018;7(4):6215-6226doi: 10.21037/tcr.2018.03.05.
Lomeli, N., & Bota, D. A. (2018). Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic. Translational cancer research, 7(4), 6215-6226. https://doi.org/10.21037/tcr.2018.03.05
Lomeli, Naomi, and Bota, Daniela A. "Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic." Translational cancer research vol. 7,4 (2018): 6215-6226. doi: https://doi.org/10.21037/tcr.2018.03.05
Lomeli N, Bota DA. Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic. Transl Cancer Res. 2018 Apr;7(4):6215-6226. doi: 10.21037/tcr.2018.03.05. PMID: 31840022; PMCID: PMC6910236.
Copy Download .nbib Format: NLM
Share it on

Transl Cancer Res. 2018 Apr;7(4):6215-6226. doi: 10.21037/tcr.2018.03.05.

Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic.

Translational cancer research

Naomi Lomeli, Daniela A Bota

Affiliations

  1. Department of Pathology & Laboratory Medicine, University of California Irvine, Irvine, CA, USA.
  2. Department of Neurology, University of California Irvine, Irvine, CA, USA.
  3. Department of Neurological Surgery, University of California Irvine, Irvine, CA, USA.
  4. Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, USA.

PMID: 31840022 PMCID: PMC6910236 DOI: 10.21037/tcr.2018.03.05

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. Nature. 2012 Aug 23;488(7412):522-6 - PubMed
  2. Neuro Oncol. 2009 Apr;11(2):109-21 - PubMed
  3. Neurology. 2011 Mar 29;76(13):1126-34 - PubMed
  4. J Cell Physiol. 2018 Jan;233(1):378-386 - PubMed
  5. Sci Rep. 2016 Jan 25;6:18953 - PubMed
  6. Neuro Oncol. 2016 Jun;18(6):840-8 - PubMed
  7. J Neurooncol. 2016 Apr;127(2):209-19 - PubMed
  8. PLoS One. 2013 Apr 26;8(4):e62876 - PubMed
  9. J Neurooncol. 2014 Dec;120(3):473-81 - PubMed
  10. Nat Neurosci. 2016 Jun;19(6):798-806 - PubMed
  11. Cancer Res. 2006 Aug 15;66(16):7843-8 - PubMed
  12. Breast Cancer Res. 2012 Apr 17;14(2):R62 - PubMed
  13. J Mol Med (Berl). 2004 Aug;82(8):488-99 - PubMed
  14. Leuk Lymphoma. 2006 Jul;47(7):1369-78 - PubMed
  15. Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):25-41 - PubMed
  16. Curr Pharm Des. 2013;19(3):347-65 - PubMed
  17. Clin Cancer Res. 2015 Jan 1;21(1):87-97 - PubMed
  18. Mol Cancer Res. 2015 Nov;13(11):1445-51 - PubMed
  19. Eur J Cancer. 2016 Jul;61:94-101 - PubMed
  20. N Engl J Med. 2005 Mar 10;352(10):987-96 - PubMed

Publication Types

Grant support